
Vice President, Corporate Securities and Transactions
Allogene Therapeutics340.000 $ – 380.000 $ / an
HibridNormă întreagăLiderLimbă Obligatorie: englezăVicepreședinteLead SEC reporting, corporate governance, and strategic transaction matters for Allogene Therapeutics, a clinical-stage biotechnology company developing off-the-shelf CAR T therapies.
Deschide